FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Federal Register

Priority Review Voucher Awarded to Pharming Tech

Federal Register notice: FDA issues a priority review voucher to Pharming Technologies that was related to its rare pediatric disease drug Joenja (len...

latest-news-card-1
Medical Devices

FDA Updates Alert on O&M Halyard N95 Masks

FDA provides further clarification about a safety alert issued earlier this month that recommended against the use of certain surgical N95 respirators...

latest-news-card-1
Federal Register

Guide on Radiation Syndrome Drug Development

Federal Register notice: FDA makes available a draft guidance entitled Acute Radiation Syndrome: Developing Drugs for Prevention and Treatment.

latest-news-card-1
Human Drugs

10 Observations in Lupin FDA-483

FDA releases the form FDA-483 with 10 observations from a recent inspection at a Lupin drug manufacturing facility in Pithampur, India.

latest-news-card-1
Human Drugs

Sarepta Comments on Golodirsen PSG

Sarepta raises several points for FDA consideration on an agency draft product-specific guidance for golodirsen.

latest-news-card-1
Federal Register

GE Healthcares Carescape Patient Monitor Cleared

FDA clears a GE HealthCare 510(k) for its Carescape Canvas patient monitoring platform for precise, flexible patient care.

latest-news-card-1
Human Drugs

FDA Describes New QSAR Model

An FDA online post describes research creating new quantitative structure-activity relationship models to predict blood-brain barrier permeability.

latest-news-card-1
Human Drugs

FDA Failed to Collect $45 bil. Drug Trial Fines: Students

Johns Hopkins students who belong to Universities Allied for Essential Medicines say FDAs failure to fine companies that dont submit clinical trial da...

latest-news-card-1
FDA General

Califf Testifies on Accelerated Approvals

FDA commissioner Robert Califf tells a Senate appropriations hearing that FDA and CMS are working to make sure clinical trials for products seeking ac...

latest-news-card-1
Human Drugs

DBV Tech Gets FDA Input in pre-BLA Meeting

DBV Technologies receives written responses from FDA after a pre-BLA meeting in February about the regulatory path for investigational Viaskin Peanut ...